WASHINGTON, D.C. (WCCO) – President Obama signed into law an FDA Reauthorization bill on Monday that includes three key provision crafted by Sen. Al Franken.

The provision includes allowing the FDA to tap a deeper well of expertise from the medical device industry during the approval process, encouraging medical device makers to develop treatments for rare diseases, and requiring that the FDA withdraw guidance released by the FDA that could have created new and burdensome requirements for companies making changes to their approved devices.

“I’m pleased that President Obama signed this bill into law because it will mean that Minnesotans will have faster, safer access to innovative and potentially life-saving medical devices,” said Franken.

Click here to read more information on the bill on Sen. Franken’s website.